Needles are soon to be a thing of the past. Eli Lilly’s new GLP-1 drug, Foundayo, received approval from the Food and Drug ...

Initial real-world results of patients receiving paltusotine suggest reduced symptoms and good tolerability, while a phase 3 ...

A leading obesity medicine specialist says new oral GLP-1 drugs offer convenience but generally produce less weight loss than injectable versions like Ozempic. Pills may help patients reluctant to ...

The injection of immunotherapy directly into precancerous oral lesions may reduce risk for progression to cancer and help ...

WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological ...

Enanta Pharmaceuticals to Present Data for Zelicapavir, an Oral, Once-Daily, N-Protein Inhibitor, in Development for the Treatment of Respiratory Syncytial Virus, at ESCMID Global 2026 Enanta ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

A new gene therapy is giving people born deaf the chance to hear, often within just weeks. In a small but groundbreaking study, researchers delivered a working copy of a key hearing gene directly into ...

For over a century, scientists have chased the dream of insulin pills, but the digestive system kept destroying the drug before it could work—forcing millions of patients to rely on daily injections.

The researchers reported that step 2 randomization was stopped early due to the superiority of cabotegravir-rilpivirine to standard care at a prespecified analysis. HealthDay News — Monthly injections ...

Phoenix NP, a women-focused telehealth medical practice based in Phoenix, Arizona, has announced the availability of FDA-approved Wegovy (semaglutide) as part of its medical weight management services ...